Impact of vaccine type on HIV1 vaccine elicited antibody durability and B cell gene signature
dc.citation.doi | 10.1038/S41598-020-69007-W | |
dc.citation.epage | 15 | |
dc.citation.spage | 1 | |
dc.contributor.author | R Palli | |
dc.contributor.author | K Seaton | |
dc.contributor.author | M Piepenbrink | |
dc.contributor.author | J Hural | |
dc.contributor.author | Fatima Laher | |
dc.contributor.author | Gavin Churchyard | |
dc.contributor.author | Glenda Gray | |
dc.contributor.author | E et al | |
dc.date.accessioned | 2023-10-06T11:53:25Z | |
dc.date.available | 2023-10-06T11:53:25Z | |
dc.identifier.citation | WOS | |
dc.identifier.issn | 2045-2322 | |
dc.identifier.uri | https://hdl.handle.net/10539/36387 | |
dc.journal.title | SCIENTIFIC REPORTS | |
dc.journal.volume | 10 | |
dc.title | Impact of vaccine type on HIV1 vaccine elicited antibody durability and B cell gene signature |
Files
Original bundle
1 - 1 of 1